Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs
Author(s):
Dawes, P.; Dimic, A.; Genovese, M.C.; Heijde, D. van der; Jenkins, M.; O'Brien, C.; Oemar, B.; Vencovsky, J.; Weinblatt, M.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S198-S199
